Table 4.

Estimated Median Number of Months From HIV Diagnosis to First Viral Suppression Among Persons Aged ≥13 Years at the Time of HIV Diagnosis During 2014 – 2018 by Selected Characteristics, 33 U.S. Jurisdictions

	2014 Median Mo (IQR), No.	2015 Median Mo (IQR), No.	2016 Median Mo (IQR), No.	2017 Median Mo (IQR), No.	2018 Median Mo (IQR), No.	2014– 2018 EAPC (95% CI) P value
Sex
Male	7 (3 – 26) n = 22521	6 (3 – 23) n = 22535	6 (3 – 21) n = 22026	5 (3 – 15) n = 21163	4 (2 – 13) n = 20579	−11.5 (−11.7 to −11.2) P < 0.001
Female	6 (3 –24) n = 5091	6 (3 – 22) n = 4923	5 (2 – 18) n = 4965	5 (2 – 15) n = 4809	4 (2 – 14) n = 4801	−10.8 (−11.0 to −10.6) P < 0.001
Transmission Category ^a
Male-to-male sexual contact	7 (3 – 24) n = 18818	6 (3 – 22) n = 18602	5 (3 – 19) n = 18275	5 (2 – 15) n = 17700	4 (2 – 13) n = 17110	−11.4 (−11.7 to −11.2) P < 0.001
Male injection drug use	9 (4 – 39) n = 832	8 (3 – 31) n = 903	7 (3 – 32) n = 812	6 (3 – 25) n = 838	6 (3 – 22) n = 888	−9.5 (−10.6 to −8.6) P < 0.001
Male-to-male sexual contact and injection drug use	8 (4 – 27) n = 972	8 (3 – 24) n = 985	7 (3 – 24) n = 978	6 (3 – 17) n = 915	4 (2 – 15) n = 923	−13.1 (−14.0 to −12.2) P < 0.001
Male heterosexual contact^b	8 (4 – 34) n = 1883	6 (3 – 26) n = 2026	6 (3 – 24) n = 1946	5 (3 – 17) n = 1692	4 (2 – 15) n = 1639	−12.1 (−12.7 to −11.5) P < 0.001
Female heterosexual contact^b	6 (3 – 22) n = 4443	5 (3 – 21) n = 4193	5 (2 – 17) n = 4258	4 (2 – 14) n = 4104	4 (2 – 12) n = 4102	−11.1 (−11.3 to −10.9) P < 0.001
Female injection drug use	8 (3 – 35) n = 636	8 (3 – 31) n = 714	6 (3 – 34) n = 685	7 (3 – 26) n = 683	6 (2 – 22) n = 677	−9.4 (−10.5 to −8.4) P < 0.001
Race/Ethnicity
Black/African American	8 (4 – 34) n = 11919	7 (3 – 30) n = 11881	6 (3 – 26) n = 11800	5 (3 – 19) n = 11311	5 (2 – 16) n = 11163	−13.8 (−13.9 to −13.7) P < 0.001
Hispanic/Latino^c	7 (3 – 25) n = 6811	6 (3 – 24) n = 6844	5 (3 – 19) n = 6837	5 (2 – 15) n = 6710	4 (2 – 13) n = 6647	−11.2 (−11.7 to −10.8) P < 0.001
Other^d	6 (3 – 20) n = 2060	5 (3 – 17) n = 2006	5 (3 – 19) n = 1958	4 (2 – 12) n = 1770	4 (2 – 10) n = 1543	−11.4 (−12.0 to −10.7) P < 0.001
White	6 (3 – 16) n = 6822	5 (3 – 14) n = 6727	5 (2 – 14) n = 6396	4 (2 – 11) n = 6181	4 (2 – 10) n = 6027	−8.8 (−9.0 to −8.6) P < 0.001
Age at diagnosis
13-24 years	9 (4 – 32) n = 6458	7 (3 – 27) n = 6388	6 (3 – 22) n = 6046	5 (3 – 17) n = 5756	5 (2 – 15) n = 5391	−14.9 (−15.1 to −14.6) P < 0.001
25-34 years	7 (3 – 26) n = 8888	6 (3 – 24) n = 9191	6 (3 – 21) n = 9372	5 (2 – 16) n = 9206	4 (2 – 14) n = 9187	−12.4 (−12.6 to −12.2) P < 0.001
35-44 years	6 (3 – 22) n = 5545	6 (3 – 21) n = 5262	5 (2 – 19) n = 5038	5 (2 – 14) n = 4911	4 (2 – 10) n = 4880	−10.0 (−10.4 to −9.5) P < 0.001
45-54 years	6 (3 – 19) n = 4275	5 (3 – 16) n = 4205	5 (3 – 17) n = 4006	4 (2 – 14) n = 3678	4 (2 – 13) n = 3489	−8.4 (−8.6 to −8.1) P < 0.001
55 years and older	6 (3 – 23) n = 2446	5 (3 – 19) n = 2412	5 (3 – 18) n = 2529	5 (2 – 13) n = 2421	4 (2 – 14) n = 2433	−7.6 (−7.9 to −7.3) P < 0.001
CD4 at HIV diagnosis
CD4 ≥ 500	5 (3 – 17) n = 6676	5 (2 – 13) n = 6998	4 (2 – 11) n = 7205	4 (2 – 8) n = 7025	3 (2 – 7) n = 7246	−13.2 (−13.3 to −13.0) P < 0.001
CD4: 200 to 499	5 (3 – 12) n = 8582	5 (3 – 11) n = 8756	4 (3 – 10) n = 8742	4 (2 – 9) n = 8613	3 (2 – 7) n = 8418	−9.2 (−9.6 to −8.9) P < 0.001
CD4 < 200	5 (3 – 11) n = 6106	5 (3 – 9) n = 5800	4 (3 – 9) n = 5627	4 (2 – 9) n = 5423	4 (2 – 8) n = 5239	−6.3 (−6.6 to −6.1) P < 0.001
Unknown	29 (11 – 71) n = 6248	30 (11 – 59) n = 5904	29 (10 – 47) n = 5417	23 (9 – 35) n = 4911	23 (8 – 24) n = 4477	−6.6 (−7.7 to −5.4) P < 0.001
Residing in States that Expanded Medicaid Coverage in 2014
Yes	7 (3 – 26) n = 14570	6 (3 – 24) n = 14057	5 (2 – 21) n = 13805	4 (2 – 15) n = 13076	4 (2 – 12) n = 12649	−12.8 (−13.2 to −12.5) P < 0.001
No	7 (4 – 25) n = 13042	6 (3 – 22) n = 13401	6 (3 – 20) n = 13186	5 (3 – 16) n = 12896	5 (2 – 15) n = 12731	−10.0 (−10.2 to −9.8) P < 0.001

Median Mo = Median number of months; IQR = Interquartile range

Data by transmission category have been statistically adjusted to account for missing risk-factor information.

Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.

Hispanics/Latinos can be of any race.

Other includes American Indian/Alaska Native, Asian, Native Hawaiian/other Pacific Islander, and persons who report multiple races.